The increased incidence and epidemic occurrence of MenX meningitis in the African meningitis belt provides impetus for developing an effective vaccine for this pathogen to supplement the MenACW vaccines used in the region. A main prerequisite for successful introduction is that the vaccine will be aff...
The use of polysaccharide trivalent ACW vaccine for the control of epidemic meningococcal disease outbreaks in countries of the African meningitis belt. Re... The recommended strategy for EMD outbreak control in the African meningitis belt is based on reactive mass vaccination with the meningococcal PS...
Currently, there are no recommendations for routine vaccination against MenB. A randomized, phase 1/2 multicenter study was conducted in Spain to determine the safety and immunogenicity of a bivalent, recombinant lipoprotein (LP2086) meningococcal serogroup A and MenB vaccine (MnB rLP2086) ...